More info
Active ingredients
Ginkgo bilobate leaf extract
Release form
Capsules
Composition
Active ingredient: Ginkgo Biloba Concentration of active ingredient (mg): 40 mg
Pharmacological effect
The drug is of plant origin. It increases the body's resistance to hypoxia, especially brain tissue, inhibits the development of traumatic or toxic cerebral edema, improves cerebral and peripheral blood circulation, improves blood rheology. It has a dose-dependent regulatory effect on the vascular wall, dilates small arteries, increases the tone of the veins. Interferes with the formation of free radicals and lipid peroxidation of cell membranes. Normalizes the release, reabsorption and catabolism of neurotransmitters (norepinephrine, dopamine, acetylcholine) and their ability to bind to receptors. It improves the metabolism in organs and tissues, contributes to the accumulation of high-energy compounds in cells, increases the utilization of oxygen and glucose, and normalizes mediator processes in the central nervous system.
Pharmacokinetics
Data on the pharmacokinetics of the drug Bilobil not provided.
Indications
Insomnia (difficulty falling asleep), associated with increased nervous excitability.
Contraindications
Hypersensitivity to the components of the drug, reduced blood clotting, erosive gastritis, peptic ulcer and duodenal ulcer in the acute stage, the child's age (up to 18 years).
Use during pregnancy and lactation
With the development of hypersensitivity reactions, the use of the drug should be discontinued. Before surgery, you must inform the doctor about the use of the drug Bilobil. If dizziness and tinnitus recurs, the patient should consult a doctor. In case of sudden deterioration or loss of hearing, you should immediately consult a doctor. Patients with bleeding (hemorrhagic diathesis) and patients receiving anticoagulant therapy should consult a doctor before starting treatment with Bilobil. Bilobil contains dextrose and lactose, therefore the patient should not be prescribed galactosemia, lactase deficiency,Glucose-galactose malabsorption syndrome. The binobil contains azorubine dye (E122), which can cause allergic reactions and bronchospasm. Effects on the ability to drive motor vehicles and control mechanisms the speed of psychomotor reactions (including driving, working with moving mechanisms).
Dosage and administration
The drug is administered orally 1 capsule 3 times a day. Capsules should be swallowed with a small amount of water. The course of treatment for at least 3 months. The first signs of improvement usually appear after 1 month. Conducting a second course is possible after consulting a doctor.
Side effects
The use of the drug in patients who are constantly taking drugs that reduce blood clotting (for example, anticoagulants (direct and indirect action), acetylsalicylic acid and other NSAIDs) is not recommended. Simultaneous use with these drugs may increase the risk of bleeding due to prolonged clotting time.
Overdose
In rare cases, allergic reactions (skin rash), dyspepsia, headache, decreased blood clotting are possible.
Interaction with other drugs
Precautionary measures
special instructions
Currently, cases of overdose of the drug Bilobil were reported.